Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.
Genetics is rarely as straightforward as a single gene driving a lone health outcome. But a new study has uncovered what ...
NEW YORK – Scientists pursuing the biological roots of schizophrenia have zeroed in on a potential factor – a normal brain process that gets kicked into overdrive. The finding could someday lead to ...
When the brain's typical wiring patterns shift from the norm, it leads to psychotic disorders such as schizophrenia and ...
A 33-year-old woman hears brutal and frightening voices daily but continues her college studies. A middle-aged man, who served in the Navy and has since struggled with substance abuse, spends 10 weeks ...
The relationship between cannabis use and schizophrenia is complex. Research indicates that cannabis use is associated with an increased risk of developing schizophrenia, but it’s not clear if ...
They are more likely to die from disease. They are more likely to die from violence. They are more likely to die as they age. And they don’t live nearly as long. The life expectancy of people with ...
Thanksgiving 1972 was a bad one for Mimi Galvin. When she and her husband Don went out to dinner with his Air Force colleagues and their wives, she liked to project the image of a proud mother of an ...
LONDON (Reuters) - Scientists have identified dozens of genes that work differently in the brains of people with schizophrenia, a finding that could narrow the search for new drugs to treat the ...
Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.
Schizophrenia is a disorder that affects how people act, think, and perceive reality. It is often very difficult to treat because it has many different causes and symptoms. In a study published last ...
Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...